|
|
||||||||
Vol. 53, Issue 3, 357-380, September 2001
Department of Pharmaceutical Sciences, Wayne State University,
Detroit, Michigan (C.K.S.); and Department of Dermatology, University
of Rochester, Rochester, New York (E.W.C., A.A.G.)
I. Epidemiology of Cutaneous Drug Reactions
II. Clinical Morphology of Cutaneous Drug Reactions
A. Morbilliform Reactions
B. Urticaria
C. Fixed Drug Eruption
D. Erythema Multiforme/Stevens-Johnson Syndrome/Toxic Epidermal
Necrolysis
III. Mechanisms of Cutaneous Drug Reactions
A. Immediate-Type Immune-Mediated Drug Reactions
B. Delayed-Type Immune-Mediated Drug Reactions
C. Photosensitivity Reactions
1. Phototoxicity.
2. Photoallergy.
D. Autoimmune Syndromes
IV. Role of Viral Infection as a Predisposing Factor for Cutaneous
Drug Reactions
V. Cutaneous Drug Reactions Associated with Selected Drugs
A. Sulfonamides
B. Anticonvulsants
C. Nonsteroidal Anti-Inflammatory Drugs
D. Antiretroviral Agents
E. Cephalosporins
F. Ampicillin/Amoxicillin
Acknowledgments
References
Cutaneous drug reactions are the most frequently occurring adverse reactions to drugs. Among hospitalized patients, the incidence of these reactions ranges from 1 to 3%. The frequency of cutaneous reactions to specific drugs may exceed 10%. These reactions may range from mildly discomforting to those that are life-threatening. Anti-infective and anticonvulsant agents are among the drugs most commonly associated with adverse reactions in the skin. We describe and illustrate the clinical morphology of the most common cutaneous drug reactions, as well as drugs that most commonly precipitate specific reactions. The varied nature of the reactions that do occur, even with specific agents, indicates a multiplicity of mechanisms available whereby cutaneous drug reactions may be initiated. Although a variety of terms have been proposed for categorizing cutaneous drug reactions, we propose that reactions are best defined based upon mechanisms, where known. In this review, we assess the current knowledge of four categories of cutaneous drug reactions: immediate-type immune-mediated reactions, delayed-type immune-mediated reactions, photosensitivity reactions, and autoimmune syndromes. Moreover, we describe evidence that viral infection is an important predisposing factor for the development of cutaneous drug reactions upon drug administration. Finally, we review the current knowledge of the type and mechanisms of cutaneous drug reactions to several categories of drugs.
This article has been cited by other articles:
![]() |
W. Song and W. A. Miller Diffuse exanthema in a patient receiving varenicline Am. J. Health Syst. Pharm., July 1, 2008; 65(13): 1239 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. D. Khan, P. M. Vyas, A. A. Gaspari, and C. K. Svensson Effect of Arylhydroxylamine Metabolites of Sulfamethoxazole and Dapsone on Stress Signal Expression in Human Keratinocytes J. Pharmacol. Exp. Ther., December 1, 2007; 323(3): 771 - 777. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Roychowdhury, P. M. Vyas, and C. K. Svensson Formation and Uptake of Arylhydroxylamine-Haptenated Proteins in Human Dendritic Cells Drug Metab. Dispos., April 1, 2007; 35(4): 676 - 681. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Vyas, S. Roychowdhury, F. D. Khan, T. E. Prisinzano, J. Lamba, E. G. Schuetz, J. Blaisdell, J. A. Goldstein, K. L. Munson, R. N. Hines, et al. Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: I. Expression and Role of Cytochromes P450 J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 488 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Vyas, S. Roychowdhury, S. B. Koukouritaki, R. N. Hines, S. K. Krueger, D. E. Williams, W. M. Nauseef, and C. K. Svensson Enzyme-Mediated Protein Haptenation of Dapsone and Sulfamethoxazole in Human Keratinocytes: II. Expression and Role of Flavin-Containing Monooxygenases and Peroxidases J. Pharmacol. Exp. Ther., October 1, 2006; 319(1): 497 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Saladi, S. R. Cohen, R. G. Phelps, A. N. Persaud, and D. Rudikoff Diltiazem induces severe photodistributed hyperpigmentation: case series, histoimmunopathology, management, and review of the literature. Arch Dermatol, February 1, 2006; 142(2): 206 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Roychowdhury, P. M. Vyas, T. P. Reilly, A. A. Gaspari, and C. K. Svensson Characterization of the Formation and Localization of Sulfamethoxazole and Dapsone-Associated Drug-Protein Adducts in Human Epidermal Keratinocytes J. Pharmacol. Exp. Ther., July 1, 2005; 314(1): 43 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Torpet, C. Kragelund, J. Reibel, and B. Nauntofte ORAL ADVERSE DRUG REACTIONS TO CARDIOVASCULAR DRUGS Crit. Rev. Oral. Biol. Med., January 1, 2004; 15(1): 28 - 46. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |